Storia in 3 fonti

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics valuations are broadly in line with industry benchmarks. The company is also being offered at a discount to the average P/E multiple of 64.9x for its listed peers, according to analysts.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

m.economictimes.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

m.economictimes.comStai leggendo5 g fa

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

originale

economictimes.indiatimes.com5 g fa

Molbio Diagnostics IPO opens today: GMP at 15% — Check price band. Should you subscribe?

Molbio Diagnostics IPO at Rs 807/share, 15% GMP, raises Rs 940 crore for R&D and manufacturing capex on Truenat. Valuation below peer P/E 64.9x + revenue/PAT +42%/+18% signals opportunity in rural point-of-care diagnostics across emerging markets.

Timeline cronologica

sabato 8 agosto 2026·thehindubusinessline.com
Molbio Diagnostics raises ₹281 cr from anchor investors ahead of IPO
Molbio Diagnostics raises ₹281.5 crore from anchor investors ahead of its IPO, set to open for subscription on August 10.
sabato 8 agosto 2026·economictimes.indiatimes.com
Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPO
Molbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. The company aims to raise between Rs 904…

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Confronto fonti

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Molbio Diagnostics IPO opens today: GMP at 15% — Check price band. Should you subscribe?

Timeline cronologica

Molbio Diagnostics raises ₹281 cr from anchor investors ahead of IPO

Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPO

Dhoot Transmission, Molbio Diagnostics IPOs see over 70 times subscription on closing day

Molbio IPO: Should Investors Subscribe?

World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor round

Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?

Molbio Diagnostics IPO: Analyst recommendations—should you subscribe or give it a miss?

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Molbio Diagnostics IPO opens today: GMP at 15% — Check price band. Should you subscribe?

Molbio IPO Day 2: GMP hits at 17% listing gains. Should you bid?

Screening India’s healthcare diagnostics market

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Dhoot Transmission, Molbio Diagnostics IPOs see over 70 times subscription on closing day